GlassScriptPhysician profile
Diana C Connor
NPI 1487642781
$1,805.47
in general payments reported to CMS, 2019-2025
29 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $87.64 · 2021: $289 · 2022: $291 · 2023: $285 · 2024: $260 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234.76 | 2019-2025 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $208.11 | 2023-2025 | Veozah |
| Pfizer INC. | $149.18 | 2021-2024 | |
| Gynesonics, INC. | $114.33 | 2021 | |
| Therapeuticsmd, INC. | $96.43 | 2019-2022 | |
| Coopersurgical, INC. | $95.75 | 2021-2025 | Summit Doppler, Paragard T 380a |
| Mayne Pharma Commercial LLC | $88.17 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $87.74 | 2023-2025 | Myfembree |
| Allergan, INC. | $78.53 | 2019-2020 | |
| Exact Sciences Corporation | $76.08 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $57.91 | 2019-2025 | |
| Aspira Women'S Health INC | $57.71 | 2022 | |
| Amgen INC. | $49.05 | 2020-2021 | |
| Medtronic, INC. | $42.45 | 2025 | Truclear |
| Exeltis, USA INC. | $38.87 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $36.60 | 2022-2023 | |
| Daiichi Sankyo INC. | $33.46 | 2019 | |
| Vertical Pharmaceuticals, LLC | $31.16 | 2019 | |
| Sage Therapeutics, LLC | $28.95 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $27.61 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $27.45 | 2019-2021 | |
| Covidien LP | $25.96 | 2019 | |
| Baxter Healthcare | $21.91 | 2019 | |
| Evofem Biosciences, INC. | $20.22 | 2022 | |
| Shield Therapeutics INC | $17.52 | 2023 | Accrufer |
| Millicent US INC | $16.77 | 2020 | |
| Hologic Sales and Service, LLC | $14.74 | 2025 | Acessa Provu System, Novasure, Fluent Fluid Management System |
| Agile Therapeutics, INC. | $14.57 | 2022 | |
| Organon LLC | $13.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.